|
|
|
The Ratio of Key Metabolic Transcripts is a Predictive Biomarker of Breast Cancer Metastasis to the Lung
11:00 AM - 12:00 PM
NCI Rising Scholars: Cancer Research Seminar Series
Speaker: Deepti Mathur, PhD, Memorial Sloan-Kettering Cancer Center (F32 Awardee)
Register for Virtual Attendance
| | | |
|
|
Immune Microenvironment in Breast Cancer Metastasis
Institute for Immunology Seminar Series
12:00 PM - 1:00 PM
Speaker: Devon Lawson, PhD (UCI)
Thorp Conference Center, Gross Hall 4th Floor
| | | |
|
|
Treating Colon Cancer: What's New
7:00 PM - 8:00 PM
Medicine in Our Backyard Series hosted by Newport Beach Public Foundation
Speaker: Valery Vilchez Parra, MD, UCI
Friends Room - Newport Beach Public Library
Register
| | | |
|
|
CRI Conquering Cancer Seminar Series: Colon Cancer
6:00 PM - 7:30 PM
Speakers: Eric Hanse, PhD, Oliver Eng, MD, Daniel Rivas, MA
Sprague Hall 105
Register
| | | |
|
|
Cancer Chemoprevention: New Opportunities
2:50 PM - 3:20 PM
Speaker: Rajesh Agarwal, PhD, University of Colorado Anschutz Medical Campus
Functional Heterogeneity in Head and Neck Cancer
3:20 PM - 3:50 PM
Speaker: Rana P. Singh, PhD, Jawaharlal Nehru University
Sprague Hall 105
Questions? Contact Xiaolin Zi
| | | |
|
|
Advancing Physician Scientist Careers in Dermatology
4:00 PM - 5:00 PM
Physician Scientist Collective: Distinguished Speaker Series
Speaker: Maryam Asgari, MD, PhD, University of Colorado, Aurora
Sprague Hall 105
Register
| | | |
|
|
Personalizing Skin Cancer Risk Assessment: A Novel Approach to Skin Cancer Screening
11:00 AM - 12:00 PM
UCI SKIN Distinguished Speaker Series
Speaker: Maryam Asgari, MD, PhD, University of Colorado, Aurora
Sprague Hall 105
| | |
Belonging, Equity and Empowerment (BEE) Scene | |
Accepting Nominations! Learning about each other cultivates an inclusive environment where everyone feels empowered to contribute and succeed. Nominate a colleague for a spotlight showcasing their unique stories beyond their roles at the CFCCC. Faculty, staff, and self-nominations are encouraged.
| | |
|
Beyond Cancer Spotlight: Oliver Eng
Oliver Eng, MS, FACP (He/Him) is an Associate Professor of Surgery, Division of Surgical Oncology and Associate Director, Peritoneal Surface Malignancy Program and Surgical Oncology Fellowship. Learn more about his passion for community, collaboration, and personal triumphs.
| |
|
BEE Scene: What's the Buzz?
Check out photos from our Research Administration team's attendance at the 2024 ACCA Cancer Center Administrators Forum (CCAF) in Philadelphia, where they connected with national cancer centers and shared best practices!
Want to share your team photo? Email cfcccadmin@hs.uci.edu.
| |
Research Admin team at Citizens Bank Park, home of the Philadelphia Phillies (pictured left to right: April Bagaporo, Kara McBride, Kimberly Castellanos, Melanie Funes & Hai Tran). | |
|
Congrats to the below CFCCC members on recent UCI pilot study awards!
Institute for Precision Health (IPH) Pilot Studies Award - learn more about these projects
-
Liquid Biopsy for the Early Detection of Early-Onset Colorectal Cancers, with a particular focus on Underrepresented Populations (PI: Wei, Li, PhD (SPT), Co-Is: Timothy Downing, PhD (BIDD) & Oliver Eng, MD (BIDD)
-
Spatial Transcriptomics of Vulvar Lichen Sclerosus (PI: Christina Kraus, MD, Co-Is: Qing Nie, PhD (SPT) & Xing Dai, PhD (SPT)
Susan & Henry Samueli College of Health Sciences (COHS) Pilot Studies Award - learn more about these projects
-
Augmentation of Dynamin-1 Levels Using Catalpol to Prevent Cancer-related Cognitive Impairment - ADC Study (PI: Alexandre Chan, PharmD, MPH (CC) & Munjal Acharya, PhD (BIDD)
-
Understanding Well-Being in Asian-American Prostate Cancer Survivors (PI: Michael Hoyt, PhD (CC), Co-Is: Jacqueline Kim, PhD (CC), David Lee, MD
| |
|
Call for Cancer Research Proposals
The UCI Cancer Research Institute is pleased to announce that funds are available through the American Cancer Society Institutional Research Grant. This institutional grant will fund several proposals for one year at a level up to $60,000 per award. All eligible faculty from each school at the University of California, Irvine are encouraged to apply, so long as the proposal has a clear link to some aspect of cancer research. The purpose of the seed grants is to provide pilot funds for research in both basic and clinical cancer-related problems. Learn more about eligibility and application instructions.
Applications: April 30, 2024
| |
|
Administrative Supplements for P30 Cancer Centers Support Grants (CCSG)
The Office of Cancer Centers is pleased to announce the release of the following three Notices of Funding Opportunities:
-
To Stimulate Research in Immunotherapy and Tumor Microenvironment in HIV/AIDS Cancer Patients at NCI-Designated Cancer Centers. Learn More.
-
To Stimulate Research in HIV-Associated Cancers in Aging Populations. Learn More.
-
To Stimulate Research in HIV/AIDS Cancer Research Projects at NCI-Designated Cancer Centers. Learn More.
Applications: April 5, 2024 | If you're interested in applying to any of the above supplements, please email cfcccpilots@hs.uci.edu.
| |
|
Administrative Supplements from NCI Division of Cancer Control and Population Sciences
Notice of Special Interest (NOSI) NOT-CA-24-030: Administrative supplements for contemporary modifiable exposures and cancer across the cancer control continuum. Learn More
- Applications: April 22, 2024
Notice of Special Interest (NOSI) NOT-CA-24-032: Administrative supplements to understand effects of within-group heterogeneity on cancer control outcomes in underrepresented populations. Learn More.
- Applications: April 29, 2024
(NEW) Notice of Special Interest (NOSI) NOT-CA-24-035: Administrative supplements for Assessing and Enhancing Survivorship Care. Learn More.
- Applications: June 4, 2024
If you're interested in applying to any of the above supplements, please email cfcccpilots@hs.uci.edu.
| |
|
The Biobehavioral Shared Resource (BBSR) Consultation & Comprehensive Project Request is Live
The BBSR is excited to discuss your project’s study design and needs, as well as see how our new menu of services can best support your project goals.
During our “Consultation Meeting” we’ll learn more about your project and how the BBSR can support your team. Ready to schedule? Complete the "Consultation Request" on iLab.
Questions? Contact Jose Lechuga, BBSR Core Manager.
| |
|
Biostatistics Shared Resource - In-person Walk-in or Zoom Consultations Available
Informal statistical in-person walk-in or via Zoom consultations are available to discuss your study design and statistical needs.
With Wen-pin Chen, MS, Senior Statistician & Manager for BSR:
With Thomas H. Taylor, PhD, Principal Statistician for BSR:
-
Every Wednesday from 2:00 - 3:00 PM via Zoom | No pre-booking necessary, drop in here
| |
|
For a curated list of internal, federal and foundation funding opportunities, please refer to CFCCC's Funding Opportunities webpage. Highlighted funding opportunities are listed below.
UCI & UC FUNDING OPPORTUNITIES
UCI CFCCC: A1 Bridge
Up to $20k in bridge funding to investigators who have received scores on NIH grant applications (i.e., not triaged) that have missed the funding pay line and will be resubmitted.
Applications: Due on a rolling basis
Learn More and Apply >>
| |
|
FOUNDATION FUNDING OPPORTUNITIES
(NEW) The Mark Foundation for Cancer Research - Emerging Leader Award
$750k / 3 years
LOI: April 29, 2024, 5 PM ET
Learn More and Apply >>
Melanoma Research Alliance
Focus: Advancing Drug Discovery to Identify New Therapies
Up to $250k / 2 years
Applications: March 28, 2024
Learn More and Apply >>
The Hope Foundation for Cancer Research
Multiple awards available: research support, career development and community support
Applications: various deadlines, see below link
Learn More and Apply >>
| |
|
OTHER NON-FEDERAL FUNDING OPPORTUNITIES
Robert A. Winn Diversity in Clinical Trials Career Development Award (Winn CDA) for Early-Stage Investigator Physicians
$120k / year salary supported for 2 years
Applications: May 13, 2024
Learn More and Apply >>
| |
|
FEDERAL FUNDING OPPORTUNITIES
NCI Transition Career Development Award (K22 Independent Clinical Trial Optional)
Earliest submission: May 12, 2024
Learn More and Apply >>
NCI Notice of Special Interest (NOSI): Telehealth Research in Cancer Care
First available due date: June 5, 2024
Learn More and Apply >>
CDMRP Anticipated Funding Opportunities for 2024
Melanoma Research Program | Pre-Announcement (multiple awards)
Learn More >>
Prostate Cancer Research Program | Pre-Announcement (multiple awards)
Learn More >>
Breast Cancer Research Program | Pre-Announcement (multiple awards)
Learn More >>
Ovarian Cancer Research Program | Pre-Announcement (multiple awards)
Learn More >>
Lung Cancer Research Program | Pre-Announcement (multiple awards)
Learn More >>
| | |
|
|
UC Irvine-led research team discovers role of key enzymes that drive cancer mutations
“It’s critical to understand how cancer cells accumulate mutations leading to hot spots that contribute to disease progression, drug resistance and metastasis,” said corresponding author Rémi Buisson, UCI assistant professor of biological chemistry.
Read More >>
| | |
|
|
2024 registration opens for 8th Annual UCI Anti-Cancer Challenge
The 2024 UCI Anti-Cancer Challenge will take place on Saturday, Oct. 5 for its eighth year dedicated to raising funds and awareness for critical cancer research. Registration for the annual event launched on World Cancer Day, inviting individuals to ride, run or walk in-person at UCI Aldrich Park or participate virtually.
Read More >>
| | |
|
|
Dr. Alexandre Chan Appointed as Vice Chair of Board of Pharmacy Specialties' Oncology Pharmacy Specialty Council
“As part of the Oncology Pharmacy Specialty Council, I am involved with the development of the board certification examination to ensure that we provide a consistent experience and high-quality examination development outcomes,” Chan explained.
Read More >>
| | |
|
|
Surgical first removes tumor without affecting fertility
Kassandra Gomez not only beat a rare case of vaginal cancer, her UCI Health surgeons like Dr. Jill H. Tseng also made sure she'd still be able to have children.
Read More >>
| | | | |
